These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21963649)

  • 1. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.
    Oz G; Vollmers ML; Nelson CD; Shanley R; Eberly LE; Orr HT; Clark HB
    Exp Neurol; 2011 Dec; 232(2):290-8. PubMed ID: 21963649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.
    Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G
    J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology.
    Öz G; Kittelson E; Demirgöz D; Rainwater O; Eberly LE; Orr HT; Clark HB
    Neurobiol Dis; 2015 Feb; 74():158-66. PubMed ID: 25446943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
    Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
    J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
    Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT
    J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.
    Oz G; Hutter D; Tkác I; Clark HB; Gross MD; Jiang H; Eberly LE; Bushara KO; Gomez CM
    Mov Disord; 2010 Jul; 25(9):1253-61. PubMed ID: 20310029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
    Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
    J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.
    Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ
    Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
    Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
    Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.
    Nag N; Tarlac V; Storey E
    Cerebellum; 2013 Feb; 12(1):74-82. PubMed ID: 22718440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
    Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
    PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model.
    Chintawar S; Hourez R; Ravella A; Gall D; Orduz D; Rai M; Bishop DP; Geuna S; Schiffmann SN; Pandolfo M
    J Neurosci; 2009 Oct; 29(42):13126-35. PubMed ID: 19846700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model.
    Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT
    Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.
    Venkatraman A; Hu YS; Didonna A; Cvetanovic M; Krbanjevic A; Bilesimo P; Opal P
    Hum Mol Genet; 2014 Jul; 23(14):3733-45. PubMed ID: 24594842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
    Burright EN; Clark HB; Servadio A; Matilla T; Feddersen RM; Yunis WS; Duvick LA; Zoghbi HY; Orr HT
    Cell; 1995 Sep; 82(6):937-48. PubMed ID: 7553854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1.
    Cvetanovic M; Patel JM; Marti HH; Kini AR; Opal P
    Nat Med; 2011 Oct; 17(11):1445-7. PubMed ID: 22001907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice.
    Serra HG; Byam CE; Lande JD; Tousey SK; Zoghbi HY; Orr HT
    Hum Mol Genet; 2004 Oct; 13(20):2535-43. PubMed ID: 15317756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.